Synthetic
peptides corresponding to five segments of a globoside (Gal-Gal)-binding
pilin sequence [residues 5-12 (R5-12), R65-75, R93-104, R103-116, and R131-143],
cyanogen bromide fragment II (CNBr-II, R53-163), and purified, intact Gal-Gal pili were prepared as
vaccines and tested for their efficacy in a BALB/c murine model of
pyelonephritis. Intact Gal-Gal pili, CNBr-II, and synthetic
peptides R5-12 and R65-75 engendered
antibodies that bound the homologous
pilin protein and prevented urine and renal colonization in most
vaccine recipients. Protection correlated with serum anti-pilus
IgG ELISA titers greater than or equal to 1:250. The efficacy afforded by synthetic
peptides R5-12 and R65-75 in vaccinated mice indicates that linear "
antigenic" determinants in separate
cyanogen bromide fragments encode "protective"
epitopes.
Peptides R93-104, R103-116, and R131-143 lacked efficacy, indicating that not all regions of the sequence are serologically equivalent. The crossreactivity of the
peptide antisera for different Gal-Gal
pilins was also assessed and correlated with the sequence homology of the corresponding regions. Antiserum to
peptide R65-75, which corresponds to a region of unconserved sequence in heterologous
pilins, bound only the homologous
pilin. Thus, it specifies a type-specific protective
epitope. Antiserum to synthetic
peptide R5-12, which corresponds to a region of conserved sequence, bound Gal-Gal
pilins from seven of eight
pyelonephritis strains, indicating that it specifies a crossreacting protective
epitope.